Cargando…
Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood
INTRODUCTION: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy in the human population affecting an estimated 8% of the world population, especially those living in areas of past and present malaria endemicity. Decreased G6PD enzymatic activity is associated with dr...
Autores principales: | Bancone, Germana, Gornsawun, Gornpan, Chu, Cindy S., Porn, Pen, Pal, Sampa, Bansil, Pooja, Domingo, Gonzalo J., Nosten, Francois |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940185/ https://www.ncbi.nlm.nih.gov/pubmed/29738562 http://dx.doi.org/10.1371/journal.pone.0196716 |
Ejemplares similares
-
Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient
por: Pal, Sampa, et al.
Publicado: (2019) -
Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in Mauritania
por: Djigo, Oum Kelthoum Mamadou, et al.
Publicado: (2021) -
The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis
por: Chu, Cindy S., et al.
Publicado: (2019) -
Diagnostic performances of the fluorescent spot test for G6PD deficiency in newborns along the Thailand-Myanmar border: A cohort study
por: Thielemans, Laurence, et al.
Publicado: (2018) -
Suitability of Capillary Blood for Quantitative Assessment of G6PD Activity and Performances of G6PD Point-of-Care Tests
por: Bancone, Germana, et al.
Publicado: (2015)